The human protein p19(ARF) is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16(INK4a)/MTS1 gene

被引:48
作者
DellaValle, V [1 ]
Duro, D [1 ]
Bernard, O [1 ]
Larsen, CJ [1 ]
机构
[1] INST GENET MOL,INSERM,U301,F-75010 PARIS,FRANCE
关键词
p16(INK4a); MTS1; CDKN2; p19(ARF);
D O I
10.1038/sj.onc.1201417
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p16/MTS1/CDKN2 gene on human chromosome band 9p21 encodes two unrelated proteins: p16(INK4a), a inhibitor of the cyclin D-dependent kinases and CDK6, and the structurally unrelated p19(ARF) protein that arrests cell growth in G(1)/S and also in G(2)/M. By use of polyclonal antibodies, the human p19(ARF) (hp19(ARF)) protein has been identified in the nucleus of various cells including normal cultured fibroblasts. The level of this protein did not fluctuate throughout the cell cycle and was more elevated in fibroblasts with limited or arrested growth, suggesting that p19(ARF) accumulated in presenescent or senescent cells. Interestingly, hp19(ARF) was not detected in several hemopoietic tumor cell lines (mainly of B-type lymphoid origin) that expressed abundant amounts of the p16 beta transcript. This finding indicates that in certain tumors, the expression of hp19(ARF) RNA and protein may be uncoupled, Furthermore, it suggests that disruption of a translational mechanism may be involved in the inactivation of hp19(ARF).
引用
收藏
页码:2475 / 2481
页数:7
相关论文
共 29 条
[1]   Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts [J].
Alcorta, DA ;
Xiong, Y ;
Phelps, D ;
Hannon, G ;
Beach, D ;
Barrett, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13742-13747
[2]  
[Anonymous], 1989, SYNTHETIC OLIGONUCLE
[3]  
BOULUKOS KE, 1989, MOL CELL BIOL, V9, P995
[4]  
COLEMAN A, 1994, CANCER RES, V54, P344
[5]  
COLIGAN JE, 1995, CURRENT PROTOCOLS PR, V1
[6]  
DURO D, 1995, ONCOGENE, V11, P21
[7]  
Duro D, 1996, CANCER RES, V56, P848
[8]   Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: Analysis of a clinic-based population [J].
FitzGerald, MG ;
Harkin, DP ;
SilvaArrieta, S ;
MacDonald, DJ ;
Lucchina, LC ;
Unsal, H ;
ONeill, E ;
Koh, J ;
Finkelstein, DM ;
Isselbacher, KJ ;
Sober, AJ ;
Haber, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) :8541-8545
[9]  
Flores JF, 1996, CANCER RES, V56, P5023
[10]  
Hara E, 1996, MOL CELL BIOL, V16, P859